SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Judy Garland

PatientJudy Garland
Date of birth1993-06-10
IdentifiersMRN HR-ML005-SYN; SSN (made up) 000-05-6127
Document date2026-06-22
AuthorMargaret Ellsworth-Diaz, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care for long-term prescribed sleeping pills and stimulants that began in adolescence: a nonjudgmental assessment, a prescription drug monitoring program review, sleep, mood, anxiety and safety, nutrition, and contraception three months after childbirth [S]

History of Present Illness

This fictional modern episode addresses the presenting concerns below. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
by 1939Stimulant pills for appetite and energy and barbiturate sleeping pills given to her as a teenage studio performer, with dependence on prescribed medicines sinceD (CLM-0003, CLM-0005)
1949Hospital and sanitarium stays in her twenties, publicly described as treatment for exhaustionD (CLM-0007)
1950Suicide attempts reported publicly, including one in 1950; recorded without detailD (CLM-0006)
March 1955Birth of her third child three months before the index visitD (CLM-0010)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Secobarbital 100 mg oral capsule, two capsules (200 mg) at bedtime; prescribed elsewhere for years; continued by this clinic at the verified dose, seven days at a time, until a supervised withdrawal is planned with addiction medicineTwo capsules at bedtime; no extra dosesOral route2026-06-22 to 2026-07-06completedS
Dextroamphetamine 10 mg oral tablet, one tablet each morning; no extra doses; prescribed elsewhere for weight and energyOne tablet each morningOral route2026-06-22 to 2026-07-20completedS
Sertraline 25 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-06-22 to 2026-06-29completedS
Medroxyprogesterone acetate 150 mg/mL injection, 150 mg into the muscle every 13 weeks150 mg intramuscularly every 13 weeksIntramuscular route2026-06-22activeS

Review of Systems

Positive for the concerns in the history of present illness. Alert, warm and quick, anxious at first and then candid; speech normal in rate; no signs of intoxication or withdrawal. Mood low and worried; PHQ-9 14 with item 9 scored 0, GAD-7 13; Mood Disorder Questionnaire negative; no thoughts of suicide or self-harm now. No other systems reported as affected in this synthetic episode. [S]

General Status

Alert and engaged. Independent in all activities; groggy in the mornings and tired in the afternoons; works long days. [S]

Physical Exam

Vital signs recorded on 2026-06-22; see the Vital Signs section. Mental status: Alert, warm and quick, anxious at first and then candid; speech normal in rate; no signs of intoxication or withdrawal; Mood low and worried; PHQ-9 14 with item 9 scored 0, GAD-7 13; Mood Disorder Questionnaire negative; no thoughts of suicide or self-harm now. The physical examination is limited to the findings relevant to this synthetic episode. [S]

Structured safety assessment: current ideation absent, intent absent, plan absent, access to means reviewed: yes. Outpatient care with close follow-up. Risk factors reviewed without detail: past suicide attempts reported in earlier years, a sedative use disorder, depression, the months after childbirth, and the low mood that can follow stopping a stimulant. Barbiturates are dangerous in overdose, so means safety is part of the plan: she agreed to take the unused capsules from earlier prescriptions to a pharmacy take-back at the next visit, to keep the current supply in a locked box, and to receive no more than seven days at a time. No alcohol with the barbiturate. A written safety plan was made with her, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in her phone. Safety is reviewed at every visit. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-06-22Body height151cmS
2026-06-22Body weight46.5kgS
2026-06-22Body mass index (BMI) [Ratio]20.4kg/m2S
2026-06-22Systolic blood pressure128mm[Hg]S
2026-06-22Diastolic blood pressure84mm[Hg]S
2026-06-22Heart rate98/minS
2026-06-22Respiratory rate16/minS
2026-06-22Body temperature36.8CelS
2026-06-22Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-06-22Hemoglobin [Mass/volume] in Blood12.3g/dL12-15.5 g/dLNormalS
2026-06-22MCV [Entitic mean volume] in Red Blood Cells by Automated count86fL80-100 fLNormalS
2026-06-22Platelets [#/volume] in Blood by Automated count28410*3/uL150-400 10*3/uLNormalS
2026-06-22Ferritin [Mass/volume] in Serum or Plasma24ng/mL15-150 ng/mLNormalS
2026-06-22Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-06-22Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2026-06-22Creatinine [Mass/volume] in Serum or Plasma0.66mg/dL0.59-1.04 mg/dLNormalS
2026-06-22Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M119mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-06-22Glucose [Mass/volume] in Serum or Plasma82mg/dL70-99 mg/dLNormalS
2026-06-22Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L10-35 U/LNormalS
2026-06-22Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma18U/L7-35 U/LNormalS
2026-06-22Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma24U/L5-40 U/LNormalS
2026-06-22Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.4-4.5 mIU/LNormalS
2026-06-22Total score [DAST-10]6{score}S
2026-06-22Total score [AUDIT-C]2{score}S
2026-06-22Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]14{score}S
2026-06-22Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]13{score}S

Problems

ProblemClinical statusVerificationCodeProvenance
Sedative, hypnotic, or anxiolytic use disorder (barbiturate), moderate, with physiological dependence; began with sleeping pills given in adolescence; synthetic modern episode linked to her documented lifelong dependence on prescribed sleeping pillsactiveconfirmed F13.20S — Synthetic modern coding. Tolerance and withdrawal are not counted toward the diagnosis for a medicine taken under medical supervision; five other criteria are met. Person-first language; not a claim about her real diagnosis.
Stimulant use disorder (prescribed amphetamine), mild; began with stimulants given in adolescence for weight and energy; synthetic modern episode linked to her documented pep pillsactiveconfirmed F15.10S — Synthetic modern coding; DSM-5-TR mild stimulant use disorder maps to F15.10. Tolerance and withdrawal are not counted for a supervised prescription.
Chronic insomnia disorder, long-standing, with sleep tied to sleeping pills since adolescenceactiveconfirmed G47.00S — Synthetic modern diagnosis anchored to the documented sleeping pills.
Contraception three months after childbirth while starting an enzyme-inducing drug: injectable progestin chosen because barbiturates, including any used for the withdrawal, weaken contraceptive pills, patches, rings and implantsactiveconfirmed Z30.013S — Synthetic contraception need; the birth is documented.
Major depressive disorder, single episode, moderate, with anxious distress; Mood Disorder Questionnaire negative and no history of mania or hypomaniaactiveconfirmed F32.1S — Synthetic modern diagnosis; not a claim about her real mood. The roster's bipolar disorder lead is not supported by the sources read and is not used.

Assessment

Plan of Treatment